Huaren Pharmaceutical Co., Ltd. (SHE:300110)
China
· Delayed Price · Currency is CNY 3.280
-0.020 (-0.61%)
Mar 11, 2026, 10:25 AM CST
Huaren Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,901 | 4,161 | 4,989 | 5,013 | 5,675 | 5,592 | Upgrade
|
| Market Cap Growth | -1.20% | -16.59% | -0.47% | -11.67% | 1.48% | 12.08% | Upgrade
|
| Enterprise Value | 4,602 | 5,705 | 6,192 | 6,865 | 7,116 | 5,435 | Upgrade
|
| Last Close Price | 3.30 | 3.52 | 4.19 | 4.19 | 4.72 | 4.64 | Upgrade
|
| PE Ratio | - | - | 26.53 | 27.73 | 43.52 | 59.10 | Upgrade
|
| Forward PE | - | 41.18 | 41.18 | 41.18 | 41.18 | 41.18 | Upgrade
|
| PS Ratio | 3.11 | 3.08 | 3.05 | 3.10 | 3.64 | 4.25 | Upgrade
|
| PB Ratio | 2.74 | 3.03 | 1.80 | 1.93 | 2.32 | 2.40 | Upgrade
|
| P/TBV Ratio | 11.69 | 15.62 | 3.21 | 3.65 | 4.82 | 3.07 | Upgrade
|
| P/FCF Ratio | 15.64 | 13.98 | 19.21 | 28.54 | - | - | Upgrade
|
| P/OCF Ratio | 13.29 | 12.91 | 16.33 | 23.00 | - | - | Upgrade
|
| EV/Sales Ratio | 3.66 | 4.22 | 3.78 | 4.24 | 4.56 | 4.13 | Upgrade
|
| EV/EBITDA Ratio | 26.52 | 23.17 | 13.15 | 17.46 | 19.71 | 23.58 | Upgrade
|
| EV/EBIT Ratio | 71.80 | 43.87 | 17.95 | 28.07 | 31.40 | 46.42 | Upgrade
|
| EV/FCF Ratio | 18.45 | 19.17 | 23.84 | 39.08 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.60 | 0.93 | 0.56 | 0.64 | 0.75 | 0.23 | Upgrade
|
| Debt / EBITDA Ratio | 4.92 | 5.18 | 3.32 | 4.24 | 5.09 | 2.33 | Upgrade
|
| Debt / FCF Ratio | 3.42 | 4.29 | 6.02 | 9.52 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.44 | 0.81 | 0.48 | 0.56 | 0.58 | 0.13 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.64 | 4.52 | 2.83 | 3.69 | 3.94 | 1.34 | Upgrade
|
| Net Debt / FCF Ratio | 2.53 | 3.74 | 5.13 | 8.25 | -2.35 | -4.48 | Upgrade
|
| Asset Turnover | 0.30 | 0.32 | 0.32 | 0.30 | 0.35 | 0.43 | Upgrade
|
| Inventory Turnover | 2.99 | 2.71 | 3.13 | 3.41 | 3.00 | 3.37 | Upgrade
|
| Quick Ratio | 0.55 | 0.54 | 1.58 | 1.18 | 1.05 | 1.15 | Upgrade
|
| Current Ratio | 0.74 | 0.77 | 1.84 | 1.35 | 1.20 | 1.51 | Upgrade
|
| Return on Equity (ROE) | -65.96% | -65.84% | 7.21% | 7.19% | 5.62% | 4.23% | Upgrade
|
| Return on Assets (ROA) | 0.97% | 1.89% | 4.17% | 2.83% | 3.13% | 2.39% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.88% | 3.95% | 7.10% | 5.44% | 6.22% | 4.32% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.50% | 6.90% | 9.40% | 7.80% | 7.40% | 5.00% | Upgrade
|
| Earnings Yield | -36.13% | -32.88% | 3.77% | 3.61% | 2.30% | 1.69% | Upgrade
|
| FCF Yield | 6.39% | 7.15% | 5.21% | 3.50% | -10.69% | -1.23% | Upgrade
|
| Dividend Yield | - | - | 0.50% | 0.50% | 0.38% | 0.32% | Upgrade
|
| Payout Ratio | - | - | 45.81% | 49.44% | 54.73% | 23.74% | Upgrade
|
| Buyback Yield / Dilution | 0.08% | -0.01% | -0.04% | 0.33% | -0.23% | -1.22% | Upgrade
|
| Total Shareholder Return | 0.08% | -0.01% | 0.46% | 0.83% | 0.15% | -0.90% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.